The use of at least one salified monomer powder in an additive manufacturing process. A process for the additive manufacture of an object wherein at least one salified monomer powder is used as raw material. A 3D printing product manufactured using at least one salified monomer powder. The salified monomer powder may have a volume median diameter D50 of less than or equal to 500 μm.

A method for reducing the crystallization temperature and the melting temperature of a polyamide powder resulting from the polymerization of at least one predominant monomer, in which the reduction in the crystallization temperature is greater than the reduction in the melting temperature, the method including a step of polymerization of the at least one predominant monomer with at least one different minor comonomer polymerized according to the same polymerization process as the at least one predominant monomer, the at least one minor comonomer being chosen from aminocarboxylic acids, diamine/diacid pairs, lactams and/or lactones, and the at least one minor comonomer representing from 0.1% to 20% by weight of the total blend of the monomers(s) and comonomer(s), preferably from 0.5% to 15% by weight of the total blend, preferably from 1% to 10% by weight of the total blend.

A method for reducing the crystallization temperature and the melting temperature of a polyamide powder resulting from the polymerization of at least one predominant monomer, in which the reduction in the crystallization temperature is greater than the reduction in the melting temperature, the method including a step of polymerization of the at least one predominant monomer with at least one different minor comonomer polymerized according to the same polymerization process as the at least one predominant monomer, the at least one minor comonomer being chosen from aminocarboxylic acids, diamine/diacid pairs, lactams and/or lactones, and the at least one minor comonomer representing from 0.1% to 20% by weight of the total blend of the monomers(s) and comonomer(s), preferably from 0.5% to 15% by weight of the total blend, preferably from 1% to 10% by weight of the total blend.

Provided are methods of producing polyamides from beta-lactones. The polyamides include bio-based polyamides that may be obtained, either in part or completely, from renewable sources.

Provided are methods of producing polyamides from beta-lactones. The polyamides include bio-based polyamides that may be obtained, either in part or completely, from renewable sources.

Thermoplastic moulding composition consisting of (A) 51 to 69.9 wt % of polyamide elastomer; (B) 15 to 38 wt % of ethylene-α-olefin copolymer; (C) 3 to 25 wt % of polyamide selected from the group consisting of: PA6, PA66, PA6/66, PA610, PA612, PA614, PA616, PA6/610, PA66/610 or mixtures thereof; (D) 0.1 to 2.0 wt % of heat stabilizers based on copper and/or iodide, organic stabilizers or a mixture thereof; (E) 0 to 5.0 wt % of additives, different from (A) to (D);
where the sum of (A) to (E) makes 100 wt % of the total moulding composition, and with the proviso that the sum of (B) and (C) is in the range from 30 to 48 wt % based on the total moulding composition.

The present technology relates to compositions and methods for modulating expression of genes, which include a target oligonucleotide sequence, such as repeats of a particular oligonucleotide sequence containing 3 to 10 nucleotides. In particular aspects, the present technology relates to agents having a formula A-L-B, wherein -L- is a linker; A- is a Brd4 binding moiety; and -B is a nucleic acid binding moiety, such as a polyamide or complementary oligonucleotide, that specifically binds to the target oligonucleotide sequence.

The present technology relates to compositions and methods for modulating expression of genes, which include a target oligonucleotide sequence, such as repeats of a particular oligonucleotide sequence containing 3 to 10 nucleotides. In particular aspects, the present technology relates to agents having a formula A-L-B, wherein -L- is a linker; A- is a Brd4 binding moiety; and -B is a nucleic acid binding moiety, such as a polyamide or complementary oligonucleotide, that specifically binds to the target oligonucleotide sequence.

This invention relates to polyamide-10 and a method for preparing the same, and according to this invention, polyamide-10 having superior mechanical and thermal properties can be prepared by preparing polyamide-10 while controlling the condensation polymerization conditions of 10-aminodecanoic acid.

An example of a three-dimensional (3D) printing composition includes a build material composition and a fusing agent to be applied to at least a portion of the build material composition during 3D printing. The build material composition includes one of: (i) a thermoplastic elastomer having a flow parameter characterized by a consolidation resistance value ranging from about 8 to about 30, and a tap density characterized by an n1/2 value ranging from 5 taps to 30 taps; or (ii) a polyamide-like material having a flow parameter characterized by a consolidation resistance value ranging from about 75 to about 120, and a tap density characterized by an n1/2 value ranging from 5 taps to 30 taps. The fusing agent includes an energy absorber to absorb electromagnetic radiation to coalesce the thermoplastic elastomer or the polyamide-like material in the at least the portion.